Lilly Endowment Inc 13F Holdings
Lilly Endowment Inc's holdings from its Form 13F-HR filing for the quarter ended June 30, 2026, compared with the previous quarter (March 31, 2026). 13F filings list the long U.S. equity positions held by institutional investment managers with over $100 million under management.
Quarter
Q2 2026
Reported 13F value
$108.4B
Largest holding
Eli Lilly and Company
Biggest Buys (Q2 2026)
| Security | Change | Value of change | % of portfolio |
|---|
Biggest Sells (Q2 2026)
| Security | Change | Value of change | % of portfolio |
|---|---|---|---|
| Eli Lilly and Company | -1.52M sh | -$1.6B | 100.00% |
Top 1 Holdings
| Security | Value | % of portfolio | Change in shares |
|---|---|---|---|
| Eli Lilly and Company | $108.4B | 100.00% | -1.65% |
Values are as reported in the filing, adjusted for stock splits. Ranked by market value; options and other non-equity positions may be included where the filing lists them.
Similar-Sized Managers
- SEI Investments Co · $113.3B
- Boston Partners · $112.6B
- Allianz Asset Management GmbH · $112.2B
- Baillie Gifford & Co · $110.2B
- Cetera Investment Advisers · $109.8B
- Qube Research & Technologies Ltd · $107.6B
- Pictet Asset Management Holding SA · $104.7B
- HighTower Advisors, LLC · $103.2B
- Mackenzie Financial Corp · $100.0B
- Sanders Capital, LLC · $99.8B